| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/25/2012 | EP1879591B1 Use of azapaullones for preventing and treating pancreatic autoimmune disorders |
| 01/25/2012 | EP1550462B1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 01/25/2012 | EP1503773B9 Hepatoprotective activity of 2 -p-hydroxybenzoylmussaenosidic acid |
| 01/25/2012 | EP1434597B1 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 01/25/2012 | EP1351707B9 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 01/25/2012 | EP1343860B1 A process for preparing vegetable oil fractions rich in non-tocolic, high-melting, unsaponifiable matter |
| 01/25/2012 | EP1310494B1 PPAR (delta) ACTIVATORS |
| 01/25/2012 | CN1809561B Phenylacetamides and their use as glucokinase modulators |
| 01/25/2012 | CN102333889A A drug identification protocol for type 2 diabetes based on gene expression signatures |
| 01/25/2012 | CN102333782A Spiro azepane-oxazolidinones as kv1.3 potassium channel blockers |
| 01/25/2012 | CN102333773A Mineralocorticoid receptor antagonist and methods of use |
| 01/25/2012 | CN102333761A Scriptaid isosteres and their use in therapy |
| 01/25/2012 | CN102333568A Pharmaceutical compounds |
| 01/25/2012 | CN102333542A Pcsk9拮抗剂 Pcsk9 antagonist |
| 01/25/2012 | CN102333535A Magnesium oxide fine granules |
| 01/25/2012 | CN102333455A Composition comprising chicoric acid and/or derivatives thereof |
| 01/25/2012 | CN102329762A Lactobacillus helveticus H9 and application thereof |
| 01/25/2012 | CN102329520A Method for preparing lutein nanometer liquid |
| 01/25/2012 | CN102329325A Pyrrolopyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitors |
| 01/25/2012 | CN102329267A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 01/25/2012 | CN102327614A Combinations comprising dipeptidylpeptidase - iv inhibitor |
| 01/25/2012 | CN102327591A Phlegm-eliminating pill |
| 01/25/2012 | CN102327565A Chinese medicinal preparation with effect of reducing body weight |
| 01/25/2012 | CN102327545A Application of traditional Chinese medicinal composition in preparation of medicine for treating metabolic syndromes |
| 01/25/2012 | CN102327541A Intensified snake-honeybee nano-selenium and germanium element capsule |
| 01/25/2012 | CN102327537A Traditional Chinese medicine for treating diabetes caused by damp impairment of splenic yang and deficiency of kidney qi |
| 01/25/2012 | CN102327530A Traditional Chinese medicine for treating diabetic gout |
| 01/25/2012 | CN102327526A Traditional Chinese medicine composition for lowering blood sugar |
| 01/25/2012 | CN102327411A Traditional Chinese medicine for treating diabetic gastroparalysis |
| 01/25/2012 | CN102327405A Chinese medicine for treating diabetic peripheral neuropathy |
| 01/25/2012 | CN102327398A Traditional Chinese medicine for treating diabetic cutaneous pruritus |
| 01/25/2012 | CN102327389A Traditional Chinese medicine for comprehensively preventing and treating diabetes complications |
| 01/25/2012 | CN102327388A Traditional Chinese medicine for treating diabetic nephropathy |
| 01/25/2012 | CN102327387A Chinese medicine for treating diabetic heart disease |
| 01/25/2012 | CN102327379A Traditional Chinese medicine for treating diabetic retinopathy |
| 01/25/2012 | CN102327368A Chinese lizardtail rhizome or herb rootstock total effective fraction and preparation method and application thereof |
| 01/25/2012 | CN102327344A Traditional Chinese medicine for treating diabetic constipation |
| 01/25/2012 | CN102327340A Chinese medicine granular preparation for poultry and preparation method thereof |
| 01/25/2012 | CN102327324A Mulberry leaf total alkali extract and preparation method and application thereof |
| 01/25/2012 | CN102327309A Barberry bark extractive and use of barberry bark extractive and barberry bark |
| 01/25/2012 | CN102327296A Propolis powder and preparation method thereof |
| 01/25/2012 | CN102327295A Propolis soft capsule |
| 01/25/2012 | CN102327292A Refined powder of sheep embryo and sheep placenta and preparation method thereof |
| 01/25/2012 | CN102327291A Stock solution of sheep embryo and sheep placental peptide and preparation method thereof |
| 01/25/2012 | CN102327282A Application of pentosan polysulfate (PPS) in preparing medicine for treating diabetic nephropathy |
| 01/25/2012 | CN102327267A Pharmaceutical compositions |
| 01/25/2012 | CN102327262A Indole-3-methanol, diindolylmethane and application of derivative thereof in preparation of drug for treating diabetes |
| 01/25/2012 | CN102327238A Levocarnitine composition for injection and preparation method of levocarnitine composition |
| 01/25/2012 | CN102113984B Composition with function of reducing weight of abdomen |
| 01/25/2012 | CN102068625B Traditional Chinese medicinal composition for reducing blood sugar and blood pressure and preparation method thereof |
| 01/25/2012 | CN102048959B Dendrobium candidum compound preparation capable of regulating function of human body in two-way manner and preparation method thereof |
| 01/25/2012 | CN102048958B Compound dendrobium candidum hypoglycemic composition and preparation method thereof |
| 01/25/2012 | CN102008528B Compound sea cucumber preparation and preparation method thereof |
| 01/25/2012 | CN102008515B Construction method of ganoderma spore powder polysaccharide fingerprint and standard fingerprint of ganoderma spore powder polysaccharide |
| 01/25/2012 | CN102000244B Traditional Chinese medicine preparation for treating diabetes mellitus |
| 01/25/2012 | CN101953992B Medicine for treating diabetes |
| 01/25/2012 | CN101926839B Synthesis method of green vitamins |
| 01/25/2012 | CN101890172B Application of S100A16 gene in preparing drug for treating obesity |
| 01/25/2012 | CN101884627B Pioglitazone hydrochloride gastric retentive sustained release tablet and preparation method thereof |
| 01/25/2012 | CN101874036B Triacetyl-3-hydroxyphenyladenosine and its use for regulating blood fat |
| 01/25/2012 | CN101849933B Conjugated linoleic acid ferrite preparation and preparation method thereof |
| 01/25/2012 | CN101804122B Tomato water-soluble saponin extract and preparation method and application thereof |
| 01/25/2012 | CN101804055B Compound medicinal preparation |
| 01/25/2012 | CN101747414B Tumor necrosis factor (TNF)-alpha binding peptide and tumor necrosis factor receptor 1(TNFR1) blocking peptide and applications thereof in treatment of TNF related diseases |
| 01/25/2012 | CN101732296B Agomelatine-containing medicinal composition |
| 01/25/2012 | CN101549046B Health preserving product of north Chinese Caterpillar Fungus and glossy ganoderma |
| 01/25/2012 | CN101522205B Fat absorption inhibitor and food and drink using the same |
| 01/25/2012 | CN101474240B Method for extracting total flavone from mimosa |
| 01/25/2012 | CN101433607B Composition of Chinese medicine extract for treating diabetes |
| 01/25/2012 | CN101406642B Antihypelipidemic compound formulation |
| 01/25/2012 | CN101278743B Method for extracting unsaturated fatty acid from Silkworm pupa |
| 01/25/2012 | CN101220088B Amalgamation protein of human glucagons-like peptide-1 and uses thereof |
| 01/25/2012 | CN101119991B Salt of proline derivative, solvate thereof, and production method thereof |
| 01/24/2012 | USRE43140 Immunoregulator |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101638 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/24/2012 | US8101612 N-3-isoxazolyl-4-methyl-3-(1-((1-methylethyl)oxy)-6-phthalazinyl)benzamide; p38 kinase inhibitor; antiinflammatory, analgesic agent; rheumatoid arthritis, osteoporosis, leukemia, psoriasis, Crohn's disease, rhinitis, ulcerative colitis, dermatitis, asthma, Alzheimer's disease, type I and II diabetes |
| 01/24/2012 | US8101599 Pharmaceutical composition containing anti-hypertensive agents |
| 01/24/2012 | US8101592 Hexahydro-cyclooctyl pyrazole cannabinoid modulators |
| 01/24/2012 | US8101588 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 01/24/2012 | US8101363 Obtaining a level of a marker of systemic inflammation in individual, comparing level of marker to a predetermined value specific for diagnosis of diabetes or diabetic complications, and characterizing the individual's risk profile |
| 01/24/2012 | US8101209 Absorption in upper part oof digestive system; oral administering |
| 01/24/2012 | US8101201 Compositions comprising dietary fat complexer and methods for their use |
| 01/24/2012 | US8101188 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/24/2012 | CA2656216C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 01/24/2012 | CA2520436C Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 01/24/2012 | CA2498559C Indole derivatives or benzimidazole derivatives for modulating i.kappa.b kinase |
| 01/24/2012 | CA2496249C 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 01/24/2012 | CA2493644C Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/24/2012 | CA2455483C The use of trifluoroacetylalkyl-substituted phenyl, phenol and benzoyl derivatives in the treatment and/or prophylaxis of obesity and its concomitant and/or secondary diseases |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2402092C 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/24/2012 | CA2221730C Use of angiotensin ii type 2 receptor agonists in tissue repair |
| 01/19/2012 | WO2012009438A2 Anti-appetite adhesive compositions |
| 01/19/2012 | WO2012009289A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
| 01/19/2012 | WO2012008549A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012008474A1 Fructose absorption inhibitor |
| 01/19/2012 | WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
| 01/19/2012 | WO2012008317A1 Agent for promoting energy consumption |